Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 2 | 2023 | 398 | 1.210 |
Why?
|
| Immunotherapy | 3 | 2023 | 664 | 0.820 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2023 | 394 | 0.750 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 1222 | 0.680 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2023 | 615 | 0.670 |
Why?
|
| Melanoma | 1 | 2023 | 466 | 0.650 |
Why?
|
| Antigen Presentation | 1 | 2018 | 215 | 0.580 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 501 | 0.560 |
Why?
|
| Skin | 1 | 2018 | 581 | 0.500 |
Why?
|
| Lipids | 2 | 2023 | 271 | 0.340 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2023 | 169 | 0.320 |
Why?
|
| Immune System | 2 | 2023 | 97 | 0.240 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2023 | 5 | 0.220 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 61 | 0.220 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2023 | 30 | 0.220 |
Why?
|
| Germ-Free Life | 1 | 2023 | 75 | 0.220 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2023 | 64 | 0.210 |
Why?
|
| Down-Regulation | 1 | 2023 | 519 | 0.190 |
Why?
|
| Protein Binding | 2 | 2023 | 1484 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 2347 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2023 | 428 | 0.170 |
Why?
|
| Antigens, CD1 | 1 | 2018 | 37 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 83 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2018 | 81 | 0.160 |
Why?
|
| Natural Killer T-Cells | 1 | 2018 | 44 | 0.160 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2018 | 32 | 0.150 |
Why?
|
| Animals | 8 | 2023 | 27272 | 0.150 |
Why?
|
| Mice | 6 | 2023 | 11722 | 0.150 |
Why?
|
| Antigens | 1 | 2018 | 229 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2018 | 3370 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 634 | 0.150 |
Why?
|
| Inflammation | 3 | 2018 | 969 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 269 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2015 | 58 | 0.120 |
Why?
|
| Virus Diseases | 1 | 2015 | 97 | 0.120 |
Why?
|
| Oncolytic Virotherapy | 1 | 2014 | 42 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 275 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2023 | 592 | 0.110 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 272 | 0.110 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2012 | 19 | 0.110 |
Why?
|
| CD28 Antigens | 1 | 2012 | 90 | 0.110 |
Why?
|
| Lymphocyte Activation | 3 | 2023 | 751 | 0.100 |
Why?
|
| Neoplasms | 1 | 2023 | 3020 | 0.080 |
Why?
|
| Humans | 5 | 2023 | 88852 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 442 | 0.070 |
Why?
|
| Formates | 1 | 2023 | 7 | 0.060 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2023 | 8 | 0.060 |
Why?
|
| NAD | 1 | 2023 | 68 | 0.060 |
Why?
|
| Glycerol | 1 | 2023 | 34 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2023 | 125 | 0.050 |
Why?
|
| Phosphates | 1 | 2023 | 160 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1573 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 385 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 458 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2018 | 67 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2018 | 66 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 37 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 123 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2018 | 251 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 150 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2018 | 284 | 0.040 |
Why?
|
| Methylation | 1 | 2018 | 268 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2018 | 168 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 329 | 0.030 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2015 | 4 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 16 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1128 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2015 | 98 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 98 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2015 | 217 | 0.030 |
Why?
|
| Newcastle disease virus | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 199 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2014 | 24 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2014 | 138 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 104 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 397 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 466 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1155 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2014 | 178 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2012 | 18 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 275 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 305 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 141 | 0.030 |
Why?
|
| Lung | 1 | 2018 | 1257 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2014 | 471 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1649 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 947 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 443 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 451 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1309 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1990 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1974 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2439 | 0.020 |
Why?
|
| Female | 1 | 2015 | 45899 | 0.010 |
Why?
|
| Male | 1 | 2012 | 42135 | 0.010 |
Why?
|